Commercially available glutenases: a potential hazard in coeliac disease

BACKGROUND: The only treatment for celiac disease (CD) is a gluten-free diet (GFD). However, there is interest among patients in a medical therapy to replace or help with a GFD. Therapies include gluten-degrading enzymes (glutenases). There are glutenases available marketed as dietary supplements th...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnareddy, Suneeta, Stier, Kenneth, Recanati, Maya, Lebwohl, Benjamin, Green, Peter HR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424869/
https://www.ncbi.nlm.nih.gov/pubmed/28567117
http://dx.doi.org/10.1177/1756283X17690991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424869/
https://www.ncbi.nlm.nih.gov/pubmed/28567117
http://dx.doi.org/10.1177/1756283X17690991

Ejemplares similares